| 1 |
31988438 | Low-frequency TP53 hotspot mutation contributes to chemoresistance through clonal expansion in acute myeloid leukemia. | 2020 Jul |
3 |
| 2 |
27470351 | Histone deacetylase inhibitor, Romidepsin (FK228) inhibits endometrial cancer cell growth through augmentation of p53-p21 pathway. | 2016 Aug |
4 |
| 3 |
18413792 | Histone deacetylase inhibitor FK228 enhances adenovirus-mediated p53 family gene therapy in cancer models. | 2008 Apr |
5 |
| 4 |
18507005 | Role of histone deacetylase inhibitor in adenovirus-mediated p53 gene therapy in esophageal cancer. | 2008 Mar-Apr |
2 |
| 5 |
17230511 | The use of histone deacetylase inhibitor FK228 and DNA hypomethylation agent 5-azacytidine in human bladder cancer therapy. | 2007 Apr 15 |
2 |
| 6 |
16537920 | Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1). | 2006 Apr |
2 |
| 7 |
17341629 | The histone deacetylase inhibitor FK228 distinctly sensitizes the human leukemia cells to retinoic acid-induced differentiation. | 2006 Dec |
1 |
| 8 |
16103091 | Depletion of mutant p53 and cytotoxicity of histone deacetylase inhibitors. | 2005 Aug 15 |
1 |
| 9 |
11929951 | Modulation of p53, ErbB1, ErbB2, and Raf-1 expression in lung cancer cells by depsipeptide FR901228. | 2002 Apr 3 |
4 |
| 10 |
12642691 | The histone deacetylase inhibitor FR901228 (desipeptide) restores expression and function of pseudo-null p53. | 2002 Nov-Dec |
3 |
| 11 |
10952788 | P21-dependent g(1)arrest with downregulation of cyclin D1 and upregulation of cyclin E by the histone deacetylase inhibitor FR901228. | 2000 Sep |
2 |